Medical Technology

@xconomy.com 4 years ago

FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes

@xconomy.com 4 years ago

With $35M, Whole Biome Eyes 2020 Launch of Medical Food for Diabetes

@xconomy.com 4 years ago

HAP Partners With Livongo on Tech-Enabled Diabetes Compliance Program

@xconomy.com 5 years ago

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

@xconomy.com 5 years ago

Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More

@xconomy.com 5 years ago

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

@xconomy.com 5 years ago

MR3 Health Takes Aim at Foot Ulcers as San Antonio Tackles Diabetes